Regarding the Merk drug and OWS involvement. I
Post# of 148147
I remember when the DSMC stopped the trial on this drug a couple months ago. Then I saw that Merk bought the company.
There is no doubt in my mind that this drug is going to be approved and probably very soon.
Does anyone have an informed opinion about how this will impact our investment? It says that Merk will produce up to 100k doses by June. It sounds like there are not very many doses currently available. The US and the other countries we are working with are going to need way more doses than that, correct?